Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 6 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for AbCellera Biologics Inc have a median target of 14.00, with a high estimate of 28.00 and a low estimate of 5.00. The median estimate represents a 410.95% increase from the last price of 2.74.
High | 921.9% | 28.00 |
Med | 410.9% | 14.00 |
Low | 82.5% | 5.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Oct 31, 2024.
Average growth rate | -9.03% |
Average growth rate | +5.42% |
More ▼
Revenue history & estimates in USD
Average growth rate | -3.32% |
Average growth rate | -0.62% |
More ▼